米嶋康臣 (Yasuto Yoneshima) - マイポータル

基本情報

所属: 九州大学病院

研究者番号: 90808825
J-GLOBAL ID: 202301001367621812
researchmap会員ID: R000059181

論文

Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma

Okamura Koji, Inoue Hiroyuki, Tanaka Kentaro Ikematsu Yuki, Furukawa Rie Ota Keiichi, Yoneshima Yasuto, Iwama Eiji, Okamoto Isamu

CANCER SCIENCE 114(3) 1095-1107 2023年3月査読有り
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment

Yasuto Yoneshima, Satoshi Morita, Masahiko Ando, Atsushi Nakamura, Shunichiro Iwasawa, Hiroshige Yoshioka, Yasuhiro Goto, Masafumi Takeshita, Toshiyuki Harada, Katsuya Hirano …

CLINICAL LUNG CANCER 23(7) 585-592 2022年11月査読有り
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer

Ritsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako, Norikazu Matsuo, Taishi Harada, Yuko Tsuchiya-Kawano, Junji Kishimoto, Keiichi Ota, Yoshimasa Shiraishi, Eiji Iwama …

TRANSLATIONAL LUNG CANCER RESEARCH 2022年9月査読有り
Quantification of HER family dimers by proximity ligation assay and its clinical evaluation in non-small cell lung cancer patients treated with osimertinibRenpeng Liu 1, Keiichi Ota 2, Eiji Iwama 1, Yasuto Yoneshima 1, Kentaro Tanaka 1, Hiroyuki Inoue 3, Tetsuzo Tagawa 4, Yoshinao Oda 5, Masaki Mori 4, Yoichi Nakanishi 6, Isamu Okamoto

Renpeng Liu, Keiichi Ota, Eiji Iwama, Yasuto Yoneshima, Kentaro Tanaka, Hiroyuki Inoue, Tetsuzo Tagawa, Yoshinao Oda, Masaki Mori, Yoichi Nakanishi …

Lung Cancer 158 156-161 2022年6月査読有り
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, Shinichiro Shimamatsu, Fumihiko Hirai, Tetsuzo Tagawa, Tatsuro Okamoto, Motoharu Hamatake, Yuko Tsuchiya-Kawano, Kohei Otsubo …

BMC Cancer 22(1) 503 2022年6月査読有り
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

Kazuki Takada 1, Mototsugu Shimokawa 2 3, Shinkichi Takamori 4, Shinichiro Shimamatsu 5, Fumihiko Hirai 5, Tetsuzo Tagawa 6, Tatsuro Okamoto 7, Motoharu Hamatake 5, Yuko Tsuchiya-Kawano 8, Kohei Otsubo 8 …

BMC Cancer 22(1) 503 2022年6月査読有り
Randomized phase II study of osimertinib plus bevacizumab versus osimertinib for untreated patients with non-squamous non-small cell lung cancer harboring EGFR mutations; WJOG9717L study

Hirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori, Terufumi Kato, Shunichi Sugawara, Keisuke Kirita, Yasuto Yoneshima, Koichi Azuma, Kazumi Nishino, Shunsuke Teraoka …

Journal of Thoracic Oncology 2022年5月査読有り
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC

Yasuto Yoneshima, Satoshi Morita, Masahiko Ando, Atsushi Nakamura, Shunichiro Iwasawa, Hiroshige Yoshioka, Yasuhiro Goto, Masafumi Takeshita, Toshiyuki Harada, Katsuya Hirano …

Journal of Thoracic Oncology 16(9) 1523-1532 2021年9月査読有り
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting

Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, Shinichiro Shimamatsu, Fumihiko Hirai, Tetsuzo Tagawa, Tatsuro Okamoto, Motoharu Hamatake, Yuko Tsuchiya-Kawano, Kohei Otsubo …

International Journal of Cancer 149(2) 473-482 2021年7月査読有り
Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis

Yasuto Yoneshima, Eiji Iwama, Shingo Matsumoto, Taichi Matsubara, Testuzo Tagawa, Keiichi Ota, Kentaro Tanaka, Mitsuhiro Takenoyama, Tatsuro Okamoto, Koichi Goto …

Scientific Reports 11(1) 12732 2021年6月査読有り
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Shinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, Mikako Jinnnouchi, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Mitsuhiro Takenoyama …

Cancer Immunology, Immunotherapy 70(6) 1745-1753 2021年6月査読有り
Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer

Hiroyuki Inoue, Hirono Tsutsumi, Kentaro Tanaka, Eiji Iwama, Yoshimasa Shiraishi, Aiko Hirayama, Takayuki Nakanishi, Hiroyuki Ando, Maako Nakajima, Seiji Shinozaki …

TRANSLATIONAL LUNG CANCER RESEARCH 10(6) 2475-2486 2021年6月査読有り招待有り
HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

Yasuto Yoneshima, Koji Kato, Haruna Minami, Munehiko Ikeda, Hiroyuki Watanabe, Goichi Yoshimoto, Toshihiro Miyamoto, Koichi Akashi, Yoichi Nakanishi, Isamu Okamoto

Cancer Sci. 2021年6月査読有り招待有り
Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer

Rie Furukawa, Hiroyuki Inoue, Yasuto Yoneshima, Hirono Tsutsumi, Eiji Iwama, Yuki Ikematsu, Nobuhisa Ando, Yoshimasa Shiraishi, Keiichi Ota, Kentaro Tanaka …

Lung Cancer 155 144-150 2021年5月査読有り
Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors

Shinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Ryo Toyozawa, Masafumi Yamaguchi, Tatsuro Okamoto, Yasuto Yoneshima …

Lung Cancer 152 27-33 2021年2月査読有り
Neural stem cell-specific ITPA deficiency causes neural depolarization and epilepsy

Yuichiro Koga, Daisuke Tsuchimoto, Yoshinori Hayashi, Nona Abolhassani, Yasuto Yoneshima, Kunihiko Sakumi, Hiroshi Nakanishi, Shinya Toyokuni, Yusaku Nakabeppu

JCI Insight. 2020年11月査読有り招待有り
Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation

Hirono Tsutsumi, Yasuto Yoneshima, Keiichi Ota, Kohei Otsubo, Eiji Iwama, Hiroyuki Inoue, Kentaro Tanaka, Yoichi Nakanishi, Isamu Okamoto

Clinical Lung Cancer 21(1) e21-e24 2020年1月査読有り招待有り
Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies

Yasuto Yoneshima, Kentaro Tanaka, Yoshimasa Shiraishi, Kojiro Hata, Hiroyuki Watanabe, Taishi Harada, Kohei Otsubo, Eiji Iwama, Hiroyuki Inoue, Satohiro Masuda …

Lung Cancer 130 5-9 2019年4月査読有り
Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patients

Satoshi Anai, Eiji Iwama, Yasuto Yoneshima, Kohei Otsubo, Kentaro Tanaka, Yoichi Nakanishi, Isamu Okamoto

Lung Cancer 126 156-161 2018年12月査読有り
PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements

Yasuto Yoneshima, Kayo Ijichi, Satoshi Anai, Keiichi Ota, Kohei Otsubo, Eiji Iwama, Kentaro Tanaka, Yoshinao Oda, Yoichi Nakanishi, Isamu Okamoto

Lung Cancer 118 36-40 2018年4月査読有り

もっとみる

講演・口頭発表等

miR-326は肺腺癌においてCD155発現を制御する

中西喬之, 米嶋康臣, 岡村晃資, 岩間映二, 田中謙太郎, 岡本勇

第81回日本癌学会学術総会 2022年5月
抗核抗体陽性の非小細胞肺癌における免疫チェックポイント阻害剤と細胞傷害性抗癌剤併用療法の安全性の検討

米嶋康臣, 松金良祐, 田中謙太郎, 白石祥理, 岩間映二, 家入一郎, 岡本勇

第63回日本肺癌学会学術集会 2022年12月
既治療NSCLCに対するnab-パクリタキセルの第3相試験（J-AXEL）：腎機能別サブグループ解析

米嶋康臣, 森田智視, 安藤昌彦, 中村敦, 吉岡弘鎮, 近藤征史, 三浦理, 細見幸生, 加藤晃史, 久保寿夫, 岸本淳司, 山本信之, 中西洋一, 岡本勇

第62回日本肺癌学会学術集会 2021年11月
実臨床での免疫チェックポイント阻害薬の免疫関連有害事象予測因子とその対策

米嶋康臣

第87回日本呼吸器学会九州支部秋季学術講演会 2021年10月招待有り
進行非小細胞肺癌の治療におけるnab-パクリタキセルの役割

米嶋康臣

第113回日本肺癌学会関西支部学術集会 2021年2月招待有り
Phase III study comparing nab-paclitaxel with docetaxel in patients with previously treated advanced non-small-cell lung cancer

Atsushi Nakamura, Yasuto Yoneshima, Satoshi Morita, Masahiko Ando, Shunichiro Iwasawa, Hiroshige Yoshioka, Yasuhiro Goto, Masafumi Takeshita, Toshiyuki Harada, Katsuya Hirano, Tetsuya Oguri, Masashi Kondo, Satoru Miura, Yukio Hosomi, Terufumi Kato, Toshio Kubo, Junji Kishimoto, Nobuyuki Yamamoto, Yoichi Nakanishi, Isamu Okamoto

2020 World Conference on Lung Cancer 2021年1月
既治療の進行・再発非小細胞肺癌に対するドセタキセルとnab-パクリタキセルのランダム化比較第III相試験（J-AXEL）

米嶋康臣, 森田智視, 安藤昌彦, 中村敦, 吉岡弘鎮, 近藤征史, 三浦理, 細見幸生, 加藤晃史, 久保寿夫, 岸本淳司, 山本信之, 中西洋一, 岡本勇

第61回日本肺癌学会学術集会 2020年11月

担当経験のある科目(授業)

共同研究・競争的資金等の研究課題

免疫チェックポイント分子リガンドを制御するmiRNAを用いたバイオマーカー開発

日本学術振興会科学研究費助成事業若手研究 2021年 - 2023年

米嶋康臣
学術研究支援（奨学寄附金）/免疫チェックポイント分子リガンドの制御機構の解明

大鵬薬品 2022年
学術研究支援（奨学寄附金）/特発性肺線維症合併非小細胞肺癌における線維性肺組織および腫瘍組織のTMB測定法を用いたペア解析

大鵬薬品 2021年